Table 2. Differentially abundant proteins selected by the TFold Analysis.
| Uniprot accession | Gene | Fold change | Description |
|---|---|---|---|
| Q7P105 | CV_0409 | 6, 3 | Probable bacteriophage tail sheath protein |
| Q7NYH4 | betA | 5, 0 | Glucose-methanol-choline oxidoreductase |
| Q7P164 | CV_0350 | 4, 4 | Probable phage sheath protein |
| Q7NW62 | CV_2128 | 4, 3 | Probable bacteriophage tail sheath protein |
| Q7P1F9 | glpD | 4, 1 | Glycerol-3-phosphate dehydrogenase |
| Q7P0Z0 | CV_0425 | 4, 0 | Putative uncharacterized protein |
| Q7NWP7 | metY | 3, 7 | O-acetylhomoserine (Thiol)-lyase |
| Q7NZT4 | CV_0837 | 3, 6 | Putative uncharacterized protein |
| Q7NWF3 | CV_2037 | 3, 2 | Probable dihydrolipoamide dehydrogenase |
| Q7P121 | aldB | 2, 9 | Aldehyde dehydrogenase (NAD) |
| Q7NWG7 | ald | 2, 6 | Alanine dehydrogenase |
| Q7P1P4 | fadH | −3, 1 | 2,4-dienoyl-CoA reductase FadH1 |
| Q7NYM4 | CV_1250 | −3, 4 | UPF0246 protein |
| Q7NTM7 | CV_3027 | −3, 7 | Probable ferredoxin |
These proteins presented the most significant changes in their abundance (p < 0.01). A positive fold change indicates a higher abundancy in the treatment condition.